+ Watch VRTX
on My Watchlist
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
When a Biotech misleads and overstates results from tests to investors, its game over and management should resign and give all their stock options back. What a bunch of losers. Shorts got this one right again. I am glad I was not an institutional investor in this company.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions